`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`BRISTOL-MYERS SQUIBB COMPANY
`AND PFIZER INC.,
`
`
` Plaintiffs and
`Counterclaim-Defendants,
`
`v.
`
`
`
`
`DR. REDDY’S LABORATORIES, LTD.
`AND DR. REDDY’S LABORATORIES,
`INC.,
`
`
` Defendants and
`Counterclaim-Plaintiffs.
`
`
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`C.A. No. 17-401-LPS
`
`PLAINTIFFS’ REPLY TO DEFENDANTS’ COUNTERCLAIMS
`
`Plaintiffs and Counterclaim-Defendants Bristol-Myers Squibb Company (“BMS”) and
`
`Pfizer Inc. (“Pfizer,” together with BMS, “Plaintiffs”), hereby reply to the Counterclaims of
`
`Defendants and Counterclaim-Plaintiffs Dr. Reddy’s Laboratories, Ltd. (“Dr. Reddy’s Ltd.”) and
`
`Dr. Reddy’s Laboratories, Inc. (“Dr. Reddy’s Inc.,” together with Dr. Reddy’s Ltd., “DRL”), D.I.
`
`11, as follows. Plaintiffs deny any allegation contained in DRL’s Answer and Counterclaims not
`
`expressly admitted in this Reply.
`
`COUNTERCLAIMS1
`
`1.
`
`This Paragraph contains statements to which no answer is required. To the extent
`
`an answer is required, denied.
`
`
`1
`Plaintiffs have incorporated the headings that appear in DRL’s Counterclaims. Plaintiffs
`do not necessarily agree with the characterization of such headings and do not waive any right to
`object to those characterizations.
`
`
`
`
`
`Case 1:17-cv-00401-LPS Document 13 Filed 07/26/17 Page 2 of 5 PageID #: 117
`
`2.
`
`This Paragraph contains legal conclusions to which no answer is required. To the
`
`extent an answer is required, Plaintiffs admit that DRL purports to bring these Counterclaims as an
`
`action for a declaratory judgment of non-infringement and invalidity, of one or more claims of
`
`U.S. Patent No. 9,326,945 (“the ’945 patent”) under 28 U.S.C. §§ 2201 and 2202. Plaintiffs
`
`admit that the ’945 patent was attached to the Complaint as Exhibit A.
`
`3.
`
`Plaintiffs lack knowledge or information sufficient to form a belief about the truth
`
`THE PARTIES
`
`of the allegations in this Paragraph.
`
`4.
`
`Plaintiffs lack knowledge or information sufficient to form a belief about the truth
`
`of the allegations in this Paragraph.
`
`5.
`
`Plaintiffs admit that BMS is a corporation organized and existing under the laws of
`
`the State of Delaware, having a place of business at Route 206 and Province Line Road, Princeton,
`
`New Jersey 08540. Otherwise, denied.
`
`6.
`
`Admitted.
`
`JURISDICTION AND VENUE
`
`7.
`
`This Paragraph contains legal conclusions to which no answer is required. To the
`
`extent an answer is required, Plaintiffs admit that DRL purports to bring these Counterclaims
`
`under the Patent Laws of the United States, 35 U.S.C. § 1 et seq., and the Declaratory Judgment
`
`Act, 28 U.S.C. §§ 2201 and 2202.
`
`8.
`
`This Paragraph contains legal conclusions to which no answer is required. To the
`
`extent an answer is required, Plaintiffs do not contest that the Court has jurisdiction over the
`
`subject matter of the Counterclaims. In addition, Plaintiffs admit that there is currently an actual
`
`controversy between DRL and Plaintiffs regarding the ’945 patent.
`
`
`
`- 2 -
`
`
`
`Case 1:17-cv-00401-LPS Document 13 Filed 07/26/17 Page 3 of 5 PageID #: 118
`
`9.
`
`This Paragraph contains legal conclusions to which no answer is required. To the
`
`extent an answer is required, Plaintiffs do not contest personal jurisdiction in this Court for
`
`purposes of the Counterclaims.
`
`10.
`
`This Paragraph contains legal conclusions to which no answer is required. To the
`
`extent an answer is required, Plaintiffs do not contest that venue with respect to the Counterclaims
`
`is proper in this judicial district.
`
`
`
`11.
`
`12.
`
`13.
`
`BACKGROUND
`
`Admitted.
`
`Admitted.
`
`This Paragraph contains legal conclusions to which no answer is required. To the
`
`extent an answer is required, Plaintiffs admit that there is currently an actual controversy between
`
`DRL and Plaintiffs regarding the ’945 patent.
`
`COUNT I
`
`(Declaratory Judgment of Non-Infringement of the ’945 patent)
`
`14.
`
`Plaintiffs hereby incorporate the answers set forth in response to Paragraphs 1
`
`through 13.
`
`15.
`
`16.
`
`17.
`
`18.
`
`Denied.
`
`Denied.
`
`Denied.
`
`Denied.
`
`COUNT II
`
`(Declaratory Judgment of Invalidity of the ’945 patent)
`
`19.
`
`Plaintiffs hereby incorporate the answers set forth in response to Paragraphs 1
`
`through 18.
`
`
`
`- 3 -
`
`
`
`Case 1:17-cv-00401-LPS Document 13 Filed 07/26/17 Page 4 of 5 PageID #: 119
`
`20.
`
`21.
`
`Denied.
`
`Plaintiffs state that they reserve the right to respond to any purported or alleged
`
`bases for invalidity of the ’945 patent provided by DRL. Otherwise, denied.
`
`22.
`
`23.
`
`Denied.
`
`Denied.
`
`DRL’S PRAYER FOR RELIEF
`
`Plaintiffs deny that DRL is entitled to any of the relief sought in its Counterclaims or to any
`
`relief whatsoever.
`
`
`
`Dated: July 26, 2017
`
`
`
`
`
`Respectfully submitted,
`
`FARNAN LLP
`
`/s/ Michael J. Farnan
`Joseph J. Farnan, Jr. (Bar No. 100245)
`Brian E. Farnan (Bar No. 4089)
`Michael J. Farnan (Bar No. 5165)
`919 N. Market Str., 12th Floor
`Wilmington, DE 19801
`Tel: (302) 777-0300
`Fax: (302) 777-0301
`farnan@farnanlaw.com
`bfarnan@farnanlaw.com
`mfarnan@farnanlaw.com
`
`Amy K. Wigmore (admitted pro hac vice)
`Gregory H. Lantier (admitted pro hac vice)
`Tracey C. Allen (admitted pro hac vice)
`Heather M. Petruzzi (admitted pro hac vice)
`Jeffrey T. Hantson (admitted pro hac vice)
`Wilmer Cutler Pickering Hale and Dorr LLP
`1875 Pennsylvania Ave, NW
`Washington, DC 20006
`202-663-6000
`202-663-6363
`
`Andrew J. Danford (admitted pro hac vice)
`Timothy A. Cook (admitted pro hac vice)
`
`- 4 -
`
`
`
`Case 1:17-cv-00401-LPS Document 13 Filed 07/26/17 Page 5 of 5 PageID #: 120
`
`Kevin M. Yurkerwich (admitted pro hac vice)
`Wilmer Cutler Pickering Hale and Dorr LLP
`60 State Street
`Boston, MA 02109
`617-526-6000
`617-526-5000
`
`Counsel for Plaintiffs Bristol-Myers Squibb
`Company and Pfizer Inc.
`
`
`
`
`
`- 5 -
`
`